证券代码：000833 证券简称：粤桂股份 公告编号：2025–036 广西粤桂广业控股股份有限公司 第九届监事会第二十五次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 （一）发出会议通知的时间和方式：2025年5月9日通过书面送达、 电子邮件等方式通知各位监事。 （二）召开会议的时间、地点、方式：2025年5月29日上午11:30； 广州市荔湾区流花路85号3楼321会议室；现场会议方式召开。 （三）会议应参加表决监事3人，成员有吴红柳、顾元荣（授权 王敏凌出席并表决）、王敏凌，实际参加表决的监事3人。 （四）本次监事会由吴红柳女士主持。公司副总经理、董事会秘 书、证券事务代表列席了会议。本次会议的召集、召开和表决程序符 合《公司法》和《公司章程》的有关规定。 二、监事会会议审议情况 （一）审议并通过《关于公司符合向特定对象发行 A 股股票条件 的议案》 监事会认为：根据《公司法》《证券法》《注册管理办法》等法 律、法规及规范性文件的有关规定，经对公司实际情况逐项自查，我 们认为公司符合上市公司向特定对象发行 A 股股 ...

Group 1 - The company held its 20th meeting of the 6th Board of Directors on May 16, 2025, where it unanimously agreed to waive the advance notice requirement for the meeting [2][3] - All 9 directors attended the meeting, which was presided over by Chairman Shi Jianwei, and the procedures complied with relevant laws and regulations [4][5] - The Board approved the adjustment of the plan for issuing A-shares to specific targets, with a total fundraising amount not exceeding 201.76 million yuan [6][9] Group 2 - The adjusted fundraising amount is a reduction from the previous cap of 366.09 million yuan, due to the company's financial investments exceeding 10% of its net assets [9][54] - The company plans to use the raised funds for projects related to precision braking and transmission components, as well as precision industrial bearing production lines, which align with its core business [38] - The company has a well-established talent team and technical capabilities to support the implementation of the fundraising projects [39][40] Group 3 - The company will take measures to mitigate the dilution of immediate returns resulting from the issuance, including enhancing production and sales of existing products [41][42] - The company has committed to improving its governance structure to ensure shareholder rights are protected and to maintain effective oversight [43] - The company will accelerate the investment project timelines to enhance its production capacity and market competitiveness [44]

江苏南方精工股份有限公司 监事会关于调整公司向特定对象发行 A 股股票相关事项的 书面审核意见 根据《中华人民共和国公司法》 （以下简称"《公司法》"）、 （以下简称"《公司章程》"）的有关规定，我们作为江苏南 方精工股份有限公司（以下简称"公司"）监事，在全面审核公司调整后的向特定 对象发行 A 股股票相关事项（以下简称"本次向特定对象发行股票"）相关文件 后，发表书面审核意见如下： 一、关于调整公司向特定对象发行 A 股股票方案的审核意见 我们认为，公司调整本次向特定对象发行股票方案中的募集资金金额事项符 合《公司法》 《证券法》 《中华人民共和国 证券法》 （以下简称"《证券法》"）、 《上市公司证券发行注册管理办法》 （以下简 称"《发行注册管理办法》"）等有关法律、法规和规范性文件以及《江苏南方精 工股份有限公司章程》 《发行注册管理办法》及其他有关法律、法规、规章和规 范性文件的规定，方案合理、切实可行。 二、关于公司向特定对象发行 A 股股票预案（修订稿）的议案的审核意见 我们认为，公司编制的《江苏南方精工股份有限公司 2025 年度向特定对象 发行 A 股股票预案（修订稿）》符合《公司法》 《 ...

关于公司 2025 年度向特定对象发行 A 股股票方案及相 关事项的书面审核意见 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共 和国证券法》（以下简称"《证券法》"）、《上市公司证券发行注册管理办法》 （以下简称"《管理办法》"）等法律、法规和规范性文件及《锦州永杉锂业股 份有限公司章程》（以下简称"《公司章程》"）有关规定，锦州永杉锂业股份 有限公司（以下简称"公司"）监事会在认真审阅相关材料的基础上，就公司 象发行"）方案及相关事项发表书面审核意见如下： 一、公司符合《公司法》 《证券法》 《管理办法》等法律、法规和规范性文件 锦州永杉锂业股份有限公司监事会 袁思迦：____________ 侍孝云：_____________ 王东：_____________ 三、本次发行募集资金的投向符合国家相关政策的规定以及公司的实际情况 和发展需求，符合公司所处行业现状及发展趋势，具备必要性和可行性，符合公 司的长远发展目标和股东的利益，不存在损害公司及全体股东特别是中小股东利 益的行为。 四、公司最近五个会计年度内没有通过配股、增发、可转换公司债券等方式 募集资金，且公司前次募集资金到账时 ...

锦州永杉锂业股份有限公司 独立董事的专项意见 锦州永杉锂业股份有限公司 根据中国证券监督管理委员会《上市公司独立董事管理办法》《上海证券交 易所股票上市规则》和《锦州永杉锂业股份有限公司章程》等要求，我们作为锦 州永杉锂业股份有限公司（以下简称"公司"）的独立董事，于 2025 年 5 月 15 日召开了独立董事专门会议，对公司第五届董事会第三十五次会议的相关议案进 行了认真审议，现基于独立判断立场，审议结果如下： 一、《关于终止公司 2022 年度非公开发行 A 股股票事项的议案》 自公司公布 2022 年度非公开发行 A 股股票方案以来，公司董事会、管理层 积极推进本次非公开发行 A 股股票的各项工作。基于内外部环境变化等因素，综 合考虑资本市场环境因素及公司实际情况，为全面切实维护全体股东的利益，经 董事会审慎分析后，同意终止公司 2022 年度非公开发行 A 股股票事项。 表决结果：3 票赞成，0 票反对，0 票弃权。 二、《关于公司符合向特定对象发行 A 股股票条件的议案》 根据《中华人民共和国公司法》 《中华人民共和国证券法》 《上市公司证券发 行注册管理办法》等法律法规和规范性文件的规定，经对公 ...

新大洲控股股份有限公司 关于召开 2025 年第五次临时股东会的通知 证券代码：000571 证券简称：新大洲 A 公告编号：临 2025-047 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、召开会议的基本情况 股东会。 五次临时会议于 2025 年 5 月 15 日召开，会议审议通过了《关于提请召开公司 （3）本公司聘请的律师。 会议室。 二、会议审议事项 备注 | | | 可以投票 。 部门规章、规范性文件和《公司章程》的规定。 （1）现场会议召开时间为：2025 年 6 月 3 日（星期二）14:30 时。 （2）通过互联网投票系统投票的具体时间为：2025 年 6 月 3 日 9:15 时~15:00 时期间的任意时间。通过交易系统进行网络投票的具体时间为：2025 年 6 月 3 日 9:15~9:25,9:30~11:30 和 13:00~15:00 时。 开。 （1）在股权登记日持有公司股份的普通股股东或其代理人。截止股权登记 日 2025 年 5 月 27 日下午收市时在中国证券登记结算有限责任公司深圳分公司登 记在册的本公司全体股东。 ...

Core Viewpoint - Zhejiang Samsung New Materials Co., Ltd. has experienced a significant decline in its financial performance for the year 2024 and the first quarter of 2025, primarily due to decreased gross profit and increased operating costs, which has raised concerns about its ongoing business viability and the impact on its planned A-share issuance [1][15][17]. Group 1: 2024 Financial Performance - In 2024, the company achieved operating revenue of 1,015.50 million yuan, a year-on-year increase of 13.81%, but reported a net loss attributable to shareholders of the parent company of 65.60 million yuan, a decline of 156.55% [1][3]. - The gross profit margin decreased significantly, with gross profit falling to 142.26 million yuan, down 31.35% from the previous year [3][4]. - Major factors contributing to the decline included increased management and financial expenses, as well as a drop in gross profit from core business operations [3][4][5]. Group 2: Q1 2025 Financial Performance - For the first quarter of 2025, the company reported a net profit attributable to shareholders of the parent company of 10.30 million yuan, a decrease of 50.02% year-on-year [9][10]. - Operating revenue for Q1 2025 was 371.39 million yuan, representing a 46.36% increase compared to the same period in 2024, but the increase in operating costs led to a significant drop in profitability [10][11]. - The financial performance was adversely affected by rising operating costs and financial expenses, which increased by 137.41% compared to the previous year [10][11]. Group 3: Impact of Subsidiary Performance - The performance of Guohua Jintai, a subsidiary, significantly impacted the overall financial results, with its operations contributing to the losses reported by the parent company [4][5][13]. - Excluding the impact of Guohua Jintai, the company's net profit would have increased by 14.34% year-on-year, indicating that the core business remains viable despite the challenges faced by the subsidiary [4][5]. Group 4: Future Outlook and Strategic Initiatives - The company is optimistic about future growth, particularly with the ongoing development of the photovoltaic glass project, which is expected to become a new growth driver once fully operational [15][16]. - The issuance of A-shares is anticipated to strengthen the company's financial position, enabling it to enhance its market position in the low-temperature storage equipment sector and expand into related fields [17][18].

Core Viewpoint - Zhejiang Samsung New Materials Co., Ltd. has experienced a significant decline in net profit for the fiscal year 2024, primarily due to decreased gross profit and increased operating costs, despite a rise in revenue [2][3][4]. Financial Performance Summary - In 2024, the company reported operating revenue of 1,015.50 million yuan, a year-on-year increase of 13.81%, but a net profit attributable to shareholders of the parent company of -65.60 million yuan, a decline of 156.55% [2][3]. - The company's gross profit margin decreased from 23.22% in 2023 to 14.01% in 2024, indicating a significant drop in profitability [4][6]. - The operating costs rose to 873.24 million yuan, an increase of 27.47% compared to the previous year [3][4]. Reasons for Performance Decline - The decline in net profit is attributed to several factors, including a drop in gross profit, rising management and financial expenses, and losses from the subsidiary Guohua Jintai [3][4][6]. - Guohua Jintai's performance significantly impacted the overall results, with a net loss of 223.40 million yuan in 2024, primarily due to production inefficiencies and low market prices for photovoltaic glass [7][8][12]. Q1 2025 Performance - For the first quarter of 2025, the company achieved operating revenue of 371.39 million yuan, a 46.36% increase year-on-year, but the net profit attributable to shareholders fell by 50.02% to 10.30 million yuan [11][12]. - The gross profit margin for Q1 2025 was reported at 15.55%, down from 24.40% in Q1 2024, reflecting ongoing challenges in maintaining profitability [12][13]. Future Outlook - Despite the recent performance decline, the company maintains that its long-term growth prospects remain intact, driven by ongoing demand for energy-efficient and intelligent products in the glass door industry [16][18]. - The completion of Guohua Jintai's photovoltaic glass project is expected to improve operational performance and contribute positively to revenue in the future [16][18].

永安行科技股份有限公司 会议文件 （更新版） 为维护全体股东的合法利益，确保本次股东大会能够依法行使职权，根据《中华人民共和 国公司法》 《上市公司股东会规则》及本公司《章程》和《股东大会议事规则》的有关规定，特 制定本次股东大会会议须知，望全体参会人员严格遵守并执行： 一、股东大会召开过程中，参会股东或股东代理人（以下统称"股东"）应当以维护全体股 东的合法权益、确保大会正常秩序和议事效率为原则，认真履行法定职责。 二、参会股东依法享有发言权、质询权、表决权等各项权利。股东应认真履行法定义务， 自觉遵守大会纪律，不得侵犯其他股东的权益，以确保股东大会的正常秩序。 三、为保证本次大会的严肃性和正常秩序，切实维护股东的合法权益，务请出席大会的股 东及相关人员准时到达会场签到确认参会资格。 四、如股东拟在本次股东大会上发言，应于会议开始前在签到处登记并填写"股东发言登记 表"。股东发言或提问应围绕本次会议议题进行，简明扼要，建议每次发言时间不超过三分钟。 永安行科技股份有限公司 2025 年第一次临时股东 大会会议文件（更新版） 目 录 议案四：关于公司 2025 年度向特定对象发行 A 股股票方案论证分析报告（ ...

Core Viewpoint - Brother Technology Co., Ltd. is planning to issue A-shares to specific investors to raise funds primarily for expanding its production capacity of iodinated contrast agents, with a focus on addressing market demand and potential risks associated with capacity utilization and economic performance [1][2][3]. Group 1: Company Overview - Brother Technology Co., Ltd. was established on March 19, 2001, with a registered capital of 1,063.70 million RMB [14]. - The company operates in the pharmaceutical and specialty chemicals sectors, focusing on the production of iodinated contrast agents and other related products [14]. - The company is headquartered in Haining, Zhejiang Province, China, and is listed on the Shenzhen Stock Exchange under the stock code 002562 [14]. Group 2: Fundraising and Investment Plans - The company plans to raise up to 4,367.50 million RMB through the issuance of A-shares, with the funds allocated primarily for a project to produce 1,150 tons of iodinated contrast agents, including 600 tons of iodinated contrast agent raw materials [9][10]. - The total investment for the iodinated contrast agent project is estimated at 6,901.86 million RMB, with 5,600.00 million RMB of the raised funds designated for this project [10]. - The company has conducted feasibility studies and market analysis to ensure the viability of the investment projects [1][2]. Group 3: Risks and Challenges - The company faces risks related to the absorption of new production capacity, as the expansion from 100 tons to 700 tons of iodinated contrast agent raw materials may lead to overcapacity if market demand does not meet expectations [1][2]. - There are concerns regarding the economic performance of previous fundraising projects, particularly the "Phenol Phase II Project," which may not achieve the anticipated economic benefits [2][3]. - The company is also exposed to industry cyclicality, price fluctuations of raw materials, and regulatory uncertainties that could impact its operational performance and profitability [4][5][6].